TWi Biotechnology, Inc. (TPEX:6610)
Taiwan · Delayed Price · Currency is TWD 40.95
+0.40 (0.99%)
Sep 8, 2026, 1:59 PM CST
TWi Biotechnology Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| - | - | - | - | - | 66.4 | |
Revenue Growth | - | - | - | - | - | 5228.81% |
Cost of Revenue | - | - | - | - | - | 0.91 |
Gross Profit | - | - | - | - | - | 65.48 |
Selling, General & Admin | 52.81 | 33.07 | 29.69 | 21.15 | 15.62 | 14.12 |
Research & Development | 307.83 | 323.95 | 387.64 | 148.41 | 74.56 | 66.66 |
Operating Expenses | 360.64 | 357.02 | 417.32 | 169.56 | 90.18 | 80.79 |
Operating Income | -360.64 | -357.02 | -417.32 | -169.56 | -90.18 | -15.3 |
Interest Expense | -0.14 | -0.17 | -0.16 | -0.09 | -0.05 | -0.09 |
Interest & Investment Income | 4.28 | 5.66 | 7.43 | 2.83 | 1.67 | 1.41 |
Currency Exchange Gain (Loss) | 0.16 | -7.76 | 7.21 | -4.27 | 12.37 | -1.78 |
Other Non Operating Income (Expenses) | 0.13 | 1.78 | -86.61 | 0.39 | 0 | 0.46 |
EBT Excluding Unusual Items | -356.2 | -357.52 | -489.45 | -170.69 | -76.18 | -15.3 |
Other Unusual Items | 56.81 | 155.14 | 324.64 | 0.01 | - | - |
Pretax Income | -299.4 | -202.37 | -164.81 | -170.68 | -76.18 | -15.3 |
Net Income | -299.4 | -202.37 | -164.81 | -170.68 | -76.18 | -15.3 |
Net Income to Common | -299.4 | -202.37 | -164.81 | -170.68 | -76.18 | -15.3 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 205 | 194 | 184 | 73 | 67 | 67 |
Shares Outstanding (Diluted) | 205 | 194 | 184 | 73 | 67 | 67 |
Shares Change | -11.84% | 5.66% | 150.94% | 8.52% | - | - |
EPS (Basic) | -1.46 | -1.04 | -0.90 | -2.33 | -1.13 | -0.23 |
EPS (Diluted) | -2.22 | -1.84 | -2.67 | -2.33 | -1.13 | -0.23 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -284.68 | -287.4 | -462.03 | -134.22 | -60.24 | -34.69 |
Free Cash Flow Per Share | -1.39 | -1.48 | -2.52 | -1.83 | -0.89 | -0.51 |
Gross Margin | - | - | - | - | - | 98.63% |
Operating Margin | - | - | - | - | - | -23.04% |
Profit Margin | - | - | - | - | - | -23.04% |
Free Cash Flow Margin | - | - | - | - | - | -52.24% |
EBITDA | -328.14 | -324.28 | -393.06 | -162.33 | -82.34 | -6.72 |
EBITDA Margin | - | - | - | - | - | -10.12% |
D&A For EBITDA | 32.49 | 32.75 | 24.26 | 7.23 | 7.83 | 8.58 |
EBIT | -360.64 | -357.02 | -417.32 | -169.56 | -90.18 | -15.3 |
EBIT Margin | - | - | - | - | - | -23.04% |